Company: INDP
Filing Date: 2025-06-13
Form Type: 8-K
Source: 0001641172-25-014972
Chunk: 4

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-06-13
Form: 8-K
Item: Item 7.01
Chunk 4
---
Item       Other    

On
June 12, 2025, the Company issued a press release announcing the pricing of the private placement described above in Item 1.01. A copy
of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The
information included in this Item 7.01 of Current Report on Form 8-K, including the attached Exhibit 99.1, shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject
to the liabilities of that section, and shall not be deemed to be incorporated by reference in any filing under the Securities Act or
the Exchange Act, whether made before or after the date of this Current Report on Form 8-K, regardless of any general incorporation
language in any such filing, except as expressly set forth by specific reference in such filing.